- Home
- DAWN vs ASPI Comparison
DAWN vs ASPI Comparison
Compare DAWN & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAWN | ASPI |
|---|---|---|
| Founded | 2018 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DAWN | ASPI |
|---|---|---|
| Price | $11.33 | $6.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $27.56 | $12.00 |
| AVG Volume (30 Days) | 2.9M | ★ 6.8M |
| Earning Date | 02-24-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $133,672,000.00 | $8,383,354.00 |
| Revenue This Year | $17.88 | $108.31 |
| Revenue Next Year | $52.38 | $403.41 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 31.11 | ★ 147.78 |
| 52 Week Low | $5.64 | $3.65 |
| 52 Week High | $13.20 | $14.49 |
Technical Indicators
Market Signals| Indicator | DAWN | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 55.26 | 42.65 |
| Support Level | $11.00 | $5.82 |
| Resistance Level | $11.84 | $8.21 |
| Average True Range (ATR) | 0.92 | 0.78 |
| MACD | -0.08 | -0.18 |
| Stochastic Oscillator | 43.75 | 14.31 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.